These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35190287)

  • 61. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estes NAM III, Halperin JL, Calkins H, et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter. J Am Coll Cardiol 2008;51:865–84.
    J Am Coll Cardiol; 2012 Aug; 60(6):568. PubMed ID: 23030033
    [No Abstract]   [Full Text] [Related]  

  • 63. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
    ; ; Camm AJ; Kirchhof P; Lip GY; Schotten U; Savelieva I; Ernst S; Van Gelder IC; Al-Attar N; Hindricks G; Prendergast B; Heidbuchel H; Alfieri O; Angelini A; Atar D; Colonna P; De Caterina R; De Sutter J; Goette A; Gorenek B; Heldal M; Hohloser SH; Kolh P; Le Heuzey JY; Ponikowski P; Rutten FH
    Eur Heart J; 2010 Oct; 31(19):2369-429. PubMed ID: 20802247
    [No Abstract]   [Full Text] [Related]  

  • 64. Corrigendum to "Height is associated with incident atrial fibrillation in a large Asian cohort", [Int. J. Cardiol. 304C, (2020) 82-84].
    Park YM; Moon J; Hwang IC; Lim H; Cho B
    Int J Cardiol; 2020 Jun; 309():93-94. PubMed ID: 32223965
    [No Abstract]   [Full Text] [Related]  

  • 65. [2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].
    Sepehri Shamloo A; Dagres N; Hindricks G
    Herz; 2021 Feb; 46(1):28-37. PubMed ID: 33289046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines.
    Polidori MC; Alves M; Bahat G; Boureau AS; Ozkok S; Pfister R; Pilotto A; Veronese N; Bo M;
    Eur Geriatr Med; 2022 Feb; 13(1):5-18. PubMed ID: 34727362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Report of the editors, 2011].
    García Puig J; Gaspar Alonso-Vega G; Ríos Blanco JJ
    Rev Clin Esp; 2012 Jan; 212(1):31-9. PubMed ID: 22176930
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
    Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
    Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The value of left atrial strain and strain rate in predicting left atrial appendage stasis in patients with nonvalvular atrial fibrillation.
    Zhu MR; Wang M; Ma XX; Zheng DY; Zhang YL
    Cardiol J; 2018; 25(1):87-96. PubMed ID: 28612903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines.
    Mountfort K; Kuck KH; Schilling R
    Eur Cardiol; 2014 Dec; 9(2):120-122. PubMed ID: 30310498
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines.
    Wasmer K; Eckardt L
    Europace; 2011 Oct; 13(10):1368-74. PubMed ID: 21712281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Erratum to: "Hemoconcentration and acute heart failure, an emerging predictive factor or already established?" [Rev Clin Esp Clin. 2019;219(1):32-33].
    Cervantes CE; Manzano L
    Rev Clin Esp (Barc); 2019 Mar; 219(2):105. PubMed ID: 30823985
    [No Abstract]   [Full Text] [Related]  

  • 73. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
    Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ;
    Eur Heart J; 2010 Nov; 31(21):2677-87. PubMed ID: 20801924
    [No Abstract]   [Full Text] [Related]  

  • 74. Performance of the "CCS Algorithm" in real world patients.
    LaHaye SA; Olesen JB; Lacombe SP
    Int J Cardiol Heart Vasc; 2015 Jun; 7():18-21. PubMed ID: 28785640
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
    Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
    Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Efficacy and safety of Wenxin Granules in treatment of chronic heart failure with atrial fibrillation: a systematic review].
    Xin Y; Dai YY; Yang HX; Zhang XW; Li B
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(23):5198-5206. PubMed ID: 32237358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!'.
    Erwin Iii J; Iung B
    Heart; 2018 Dec; 104(24):2077. PubMed ID: 30482810
    [No Abstract]   [Full Text] [Related]  

  • 79. Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines.
    Yang H; Heidendael JF; de Groot JR; Konings TC; Veen G; van Dijk APJ; Meijboom FJ; Sieswerda GT; Post MC; Winter MM; Mulder BJM; Bouma BJ
    Int J Cardiol; 2018 Apr; 257():67-74. PubMed ID: 29506740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corrigendum to "Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology" [J. Cardiol. 72 (2) (2018) 113-119].
    Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H
    J Cardiol; 2018 Nov; 72(5):444. PubMed ID: 30097217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.